Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPR-15007654Phase 4Completed
Phase 4 trial of dexmedetomidine in postoperative delirium (POD) (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Postoperative delirium. Started Dec 2015; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPR-15007654.